StockData
Annovis Bio, Inc. logo

Annovis Bio, Inc. (ANVS) stock

ANVSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.75−0.09 (-11.01%)

Close on Nov 19, 2026Market cap $31.89MP/E –Yield –

Annovis Bio gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Annovis Bio

Annovis Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Annovis Bio figures

See a number that looks wrong?